Firstly, it is an honor and absolute pleasure of mine to be designated......
June 15, 2020
Brief Report on ART site Assessment of TLE to TLD Transition
M&E, Surveillance and Research Section of NCASC developed a rapid site assessment...
June 3, 2020
Virtual orientation on the use of Dolutegravir (DTG) based regimen
The orientation was conducted between May 6, 2020 and May 15, 2020
June 3, 2020
Nepal submitted 2020 Global AIDS Monitoring (GAM) reporting.
2020 Global AIDS Monitoring (GAM)reporting submitted to UNAIDS by Nepal
June 3, 2020
Guideline for Reporting Individual-level Data
NCASC developed and rolled out HIV Care and ART Tracking System
June 2, 2020
Dolutegravir (DTG)/TLD Rolled Out in Nepal
With the dissemination of new HIV testing and treatment guidelines, DTG based regimen (TLD: tenofovir, lamivudine, Dolutegravir) is the preferred first line regimen.
National Centre for AIDS and STD Control
Copyright © NCASC 2015.All rights reserved.Designed & Developed By: Mercantile Communications
Visited 2355 Times